Virology News and Research

Latest Virology News and Research

Innovative strategy uses genetically modified viruses to selectively attack tumor cells

Scientists at the IDIBAPS Biomedical Research Institute and at the Institute for Research in Biomedicine lead a study in which they have designed a new strategy to get genetically modified viruses to selectively attack tumor cells without affecting healthy tissues.

16 Mar 2017

Study shows how mutations allow HCV to elude immune responses and vaccines

Unlike its viral cousins hepatitis A and B, hepatitis C virus (HCV) has eluded the development of a vaccine and infected more than 170 million people worldwide.

16 Mar 2017

Research reveals reasons for adolescents not getting vaccinated against HPV

Concern about sexual activity is declining as a reason parents do not get their daughters the human papillomavirus (HPV) vaccine, according to a research study presented today at the Society of Gynecologic Oncology’s 2017 Annual Meeting on Women’s Cancer.

16 Mar 2017

Research findings advance development of HIV vaccines that induce broadly neutralizing antibodies

A Duke Health-led research team has described both the pathway of HIV protective antibody development and a synthetic HIV outer envelope mimic that has the potential to induce the antibodies with vaccination.

16 Mar 2017

New class of membrane-busting compounds can combat MRSA skin infections in mice

Public health officials are increasingly concerned over methicillin-resistant Staphylococcus aureus (MRSA). The bacteria have developed resistance to a number of treatments, even antibiotics of last resort in some cases.

15 Mar 2017

Bacterial cell counting and sizing using the Multisizer

In this interview, Dr. Rich Jones introduces bacterial cell counting and an example of when the Multisizer 4e from Beckman Coulter has been used for this application.

From Beckman Coulter Life Sciences - Particle Counting and Characterization 15 Mar 2017

Study: Investigational Ebola vaccine regimen induced immune response that persisted for one year

A two-vaccine regimen intended to protect against Ebola virus disease induced an immune response that persisted for approximately one year in healthy adult volunteers, according to results from a Phase 1 clinical trial published in the March 14th issue of the Journal of the American Medical Association.

15 Mar 2017

Study findings could lead to novel therapies for preventing vision loss from degenerative retinal diseases

Silencing a gene called Nrl in mice prevents the loss of cells from degenerative diseases of the retina, according to a new study.

15 Mar 2017

Natural immune molecule shows protective effect against Zika virus in mouse, monkey models

A molecule naturally produced by the immune system protects mice and monkeys against Zika virus infection, an international team of researchers has found.

14 Mar 2017

New study examines immune responses to Ebola vaccines at one year after immunization

Immune responses to Ebola vaccines at one year after vaccination are examined in a new study appearing in the March 14 issue of JAMA.

14 Mar 2017

New method can precisely track replication of yellow fever virus in host immune cells

Researchers from Princeton University's Department of Molecular Biology have developed a new method that can precisely track the replication of yellow fever virus in individual host immune cells.

14 Mar 2017

Researchers discover new way to curb chronic pain

For millions of sufferers, there is nothing more debilitating than chronic back or joint pain. It can feel like a lifetime of misery.

14 Mar 2017

Study finds vaccines to be successful in preventing pandemic flu

Vaccines are successful in preventing pandemic flu and reducing the number of patients hospitalised as a result of the illness, a study led by academics at The University of Nottingham has found.

13 Mar 2017

Pre-existing immunity to dengue virus modulates T cell response to Zika infection

Although Zika and dengue are considered different virus "species," they are so closely related that the immune system treats Zika just like another version of dengue, report researchers at La Jolla Institute for Allergy and Immunology.

13 Mar 2017

Georgia State professor receives five-year $4.1 million federal grant to develop drug targeting Ebola virus

Dr. Christopher Basler, a professor in the Institute for Biomedical Sciences at Georgia State University, director of the university's Center for Microbial Pathogenesis and a Georgia Research Alliance Eminent Scholar in Microbial Pathogenesis, has received a five-year, $4.1 million federal grant to develop a drug targeting Ebola virus.

13 Mar 2017

Cross-species transmission may play big role in virus evolution than previously thought

On occasion, a virus may jump from one host species to another and adapt to the new host. Such cross-species transmission happens more often than expected, according to new research published in PLOS Pathogens, and it may play a much bigger role in virus evolution than previously thought.

10 Mar 2017

Investigational RSV vaccine protects cattle from respiratory diseases

A novel vaccine developed by scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, protected cattle from respiratory syncytial virus (RSV) infection, according to research published online in npj Vaccines on March 8.

10 Mar 2017

Study shows how risk perception of flu vaccine differs between white and African American adults

Fewer than half of American adults get vaccinated despite strong recommendations from the Centers for Disease Control and Prevention and widespread availability of free and low-cost vaccines.

10 Mar 2017

Zika virus may also cause serious cardiovascular complications, research shows

Zika also may have serious effects on the heart, new research shows in the first study to report cardiovascular complications related to this virus, according to data being presented at the American College of Cardiology's 66th Annual Scientific Session.

10 Mar 2017

Flu can cause worse symptoms in people with asthma, research shows

People with asthma are likely to have worse symptoms when they get the flu because they have weaker immune systems, new Southampton research has shown.

9 Mar 2017

Virology News and Research

Latest Virology News and Research

Innovative strategy uses genetically modified viruses to selectively attack tumor cells

Study shows how mutations allow HCV to elude immune responses and vaccines

Research reveals reasons for adolescents not getting vaccinated against HPV

Research findings advance development of HIV vaccines that induce broadly neutralizing antibodies

New class of membrane-busting compounds can combat MRSA skin infections in mice

Bacterial cell counting and sizing using the Multisizer

Study: Investigational Ebola vaccine regimen induced immune response that persisted for one year

Study findings could lead to novel therapies for preventing vision loss from degenerative retinal diseases

Natural immune molecule shows protective effect against Zika virus in mouse, monkey models

New study examines immune responses to Ebola vaccines at one year after immunization

New method can precisely track replication of yellow fever virus in host immune cells

Researchers discover new way to curb chronic pain

Study finds vaccines to be successful in preventing pandemic flu

Pre-existing immunity to dengue virus modulates T cell response to Zika infection

Georgia State professor receives five-year $4.1 million federal grant to develop drug targeting Ebola virus

Cross-species transmission may play big role in virus evolution than previously thought

Investigational RSV vaccine protects cattle from respiratory diseases

Study shows how risk perception of flu vaccine differs between white and African American adults

Zika virus may also cause serious cardiovascular complications, research shows

Flu can cause worse symptoms in people with asthma, research shows

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows